Generation of mutator mutants during carcinogenesis

DNA Repair

Volumn 5, Issue 3, 2006, Pages 294-302

  Venkatesan, Ranga N ^a   Bielas, Jason H ^a   Loeb, Lawrence A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer; Carcinogenesis; Mutator phenotype; Polymerase; Random mutations

Indexed keywords

CYTOSINE DEAMINASE; DNA POLYMERASE; MUTAGENIC AGENT;

BIOCHEMISTRY; CANCER; CANCER CELL; CARCINOGENESIS; CATALYSIS; CELL LINEAGE; CELL PROLIFERATION; DNA REPAIR; DNA SYNTHESIS; GENE REPLICATION; GENE SEQUENCE; GENOME; HUMAN; HYPOTHESIS; MUTAGENESIS; MUTANT; MUTATION; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; VIRUS INDUCTION;

EID: 32644463172     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2005.10.012     Document Type: Review

References (91)

1. P. Armitage, and R. Doll The age distribution of cancer and a multi-stage theory of carcinogenesis Br. J. Cancer 8 1954 1 12
2. A.L. Jackson, and L.A. Loeb The mutation rate and cancer Genetics 148 1998 1483 1490
3. T.A. Kunkel, and K. Bebenek DNA replication fidelity Annu. Rev. Biochem. 69 2000 497 529
4. B.J.P. Huntly, and D.G. Gilliland Leukaemia stem cells and the evolution of cancer-stem-cell research Nat. Rev. Cancer 5 2005 311 321
5. T. Reya, and H. Clevers Wnt signalling in stem cells and cancer Nature 434 2005 843 850
6. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 3 1997 730 737
7. M. Al-Haji, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 100 2003 3983 3988
8. M.F. Kielman, M. Rindapaa, C. Gaspar, N. van Poppel, C. Breukel, S. van Leeuwen, M.M. Taketo, S. Roberts, R. Smits, and R. Fodde Apc modulates embyonic stem-cell differentiation by controlling the dosage of β-catenin signaling Nat. Genet. 32 2002 594 605
9. H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraseer, and H.I. Kornblum Cancerous stem cells can arise from pediatric brain tumors Proc. Natl. Acad. Sci. U.S.A. 100 2003 15178 15183
10. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cuismano, and P.B. Dirks Identification of human brain tumour initiating cells Nature 432 2004 396 401
11. R.B. Cervantes, J.R. Stringer, C. Shao, J.A. Tischfield, and P.J. Stambrook Embryonic stem cells and somatic cells differ in mutation frequency and type Proc. Natl. Acad. Sci. U.S.A. 99 2002 3586 3590
12. J. Cairns Somatic stem cells and the kinetics of mutagenesis and carcinogenesis Proc. Natl. Acad. Sci. U.S.A. 99 2002 10567 10570
13. A.L. Jackson, and L.A. Loeb The contribution of endogenous sources of DNA damage to the multiple mutations in cancer Mutat. Res. 477 2001 187 198
14. C. Lengauer, K.W. Kinzler, and B. Vogelstein Genetic instability in colorectal cancers Nature 386 1997 623 627
15. H. Rajagopalan, M.A. Nowak, B. Vogelstein, and C. Lengauer The significance of unstable chromosomes in colorectal cancer Nat. Rev. Cancer 2003 695 701
16. M. Perucho Cancer of the microsatellite mutator phenotype Biol. Chem. 377 1996 675 684
17. R. Li, A. Sonik, R. Stindl, D. Rasnick, and P. Duesberg Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy Proc. Natl. Acad. Sci. U.S.A. 97 2000 3236 3241
18. P. Duesberg, C. Rausch, D. Rasnick, and R. Hehlmann Genetic instability of cancer cells is proportional to their degree of aneuploidy Proc. Natl. Acad. Sci. U.S.A. 95 1998 13692 13697
19. S. Hanks, K. Coleman, S. Reid, A. Plaja, H. Firth, D. Fitzpatrick, A. Kidd, K. Mehes, R. Nash, N. Robin, N. Shannon, J. Tolmie, J. Swansbury, A. Irrthum, J. Douglas, and N. Rahman Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B Nat. Genet. 36 2004 1159 1161
20. J.H. Hoeijmakers Genome maintenance mechanisms for preventing cancer Nature 411 2001 366 374
21. K. Shinmura, S. Yamaguchi, T. Saitoh, T. Kohno, and J. Yokota Somatic mutations and single nucleotide polymorphisms of base excision repair genes involved in the repair of 8-hydroxyguanine in damaged DNA Cancer Lett. 166 2001 65 69
22. N. Al-Tassan, N.H. Chmiel, J. Maynard, N. Fleming, A.L. Livingston, G.T. Williams, A.K. Hodges, D.R. Davies, S.S. David, J.R. Sampson, and J.P. Cheadle Inherited variants of MYH associated with somatic G:C → T:A mutations in colorectal tumors Nat. Genet. 30 2002 227 232
23. C. Masutani, R. Kusumoto, S. Iwai, and F. Hanaoka Mechanisms of accurate translesion synthesis by human DNA polymerase eta EMBO J. 19 2000 3100 3109
24. Z. Livneh DNA damage control by novel DNA polymerases: translesion replication and mutagnesis J. Biol. Chem. 276 2001 25639 25642
25. E.C. Friedberg, R. Wagner, and M. Radman Specialized DNA polymerases, cellular survival, and the genesis of mutations Science 296 2002 1627 1630
26. M.F. Goodman, and B. Tippin The expanding polymerase universe Nat. Rev. Mol. Cell. Biol. 1 2000 101 109
27. L. Haracska, I. Unk, R.E. Johnson, E. Johansson, P.M. Burgers, S. Prakash, and L. Prakash Roles of yeast DNA polymerases delta and zeta and of Rev1 in the bypass of abasic sites Genes Dev. 15 2001 945 954
28. E.C. Friedberg, R. Wagner, and M. Radman Specialized DNA polymerases, cellular survival, and the genesis of mutations Science 296 2002 1627 1630
29. T. Matsuda, K. Bebenek, C. Masutani, F. Hanaoka, and T.A. Kunkel Low fidelity DNA synthesis by human DNA polymerase-eta Nature 404 2000 1011 1013
30. J.E. Cleaver, and K.H. Kraemer Xeroderma pigmentosum C.R. Scriver A.L. Beudet W.S. Sktm D. Valle Metabolic Basis of Inherited Disease 1989 McGraw-Hill New York, NY 2949 2971
31. C. Masutani, R. Kusumoto, A. Yamada, N. Dohmae, M. Yokoi, M. Yuasa, M. Araki, S. Iwai, K. Takio, and F. Hanaoka The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta Nature 399 1999 700 704
32. B.F. Johnson, B. Weiner, R. Marwaha, and J. Johnson The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels J. Clin. Pharmacol. 26 1986 258 263
33. T. Itoh, S. Linn, R. Kamide, H. Tokushige, N. Katori, Y. Hosaka, and M. Yamaizumi Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation J. Invest. Dermatol. 115 2000 981 985
34. Y. Zhang, F. Yuan, X. Wu, and Z. Wang Preferential incorporation of G opposite template T by the low-fidelity human DNA polymerase iota Mol. Cell. Biol. 20 2000 7099 7108
35. Y. Zhang, F. Yuan, X. Wu, J.-S. Taylor, and Z. Wang Response of human DNA polymerase ι to DNA lesions Nucleic Acids Res. 29 2001 928 935
36. A. Tissier, E.G. Frank, J.P. McDonald, S. Iwai, F. Hanaoka, and R. Woodgate Misinsertion and bypass of thymine-thymine dimers by human DNA polymerase ι EMBO J. 19 2000 5259 5266
37. A. Vaisman, C. Masutani, F. Hanaoka, and S.G. Chaney Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta Biochemistry 39 2000 4575 4580
38. A. Faill, S. Aoufouchi, E. Flathr, Q. Gueranger, C.-A. Reynaud, and J.-C. Weil Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase ι Nature 419 2002 944 947
39. J.P. McDonald, E.G. Frank, B.S. Plosky, I.B. Rogozin, M.C.F. Hanaoka, R. Woodgate, and P.J. Gearhart 129-Derived strains of mice are deficient in DNA polymerase ι and have normal immunoglobulin hypermutation J. Exp. Med. 198 2003 635 643
40. Y. Zhang, F. Yuan, X. Wu, M. Wang, O. Rechkoblit, J.-S. Taylor, N.E. Geacintov, and Z. Wang Error-free and error-prone lesion bypass by human DNA polymerase k in vitro Nucleic Acids Res. 28 2000 4138 4146
41. V.L. Gerlach, W.J. Feaver, P.L. Fischhaber, and E.C. Friedberg Purification and characterization of pol kappa, a DNA polymerase encoded by the human DINB1 gene J. Biol. Chem. 276 2001 92 98
42. 6-ethenodeoxyadenosine J. Biol. Chem. 276 2001 18717 18721
43. P.L. Fischhaber, V.L. Gerlach, W.J. Feaver, Z. Hatahet, S.S. Wallace, E.C. Friedberg, Human DNA polymerase κ bypasses and extends beyond thymine glycols during translesion synthesis in vitro, preferentially incorporating correct nucleotides, J. Biol. Chem. 277 (2002) 37604-37611.
44. 6-dA lesions catalyzed by DNA bypass polymerases J. Biol. Chem. 277 2002 30488 30494
45. S. Avkin, M. Goldsmith, S. Velasco-Miguel, N. Geacintov, E.C. Friedberg, and Z. Livneh Quantitative analysis of translesion DNA synthesis across a benzo[a]pyrene-guanine adduct in mammalian cells J. Biol. Chem. 279 2004 53298 53305
46. T. Ogi, Y. Shinkai, K. Tanaka, and H. Ohmori Pol κ protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene Proc. Natl. Acad. Sci. U.S.A. 99 2002 15548 15553
47. X. Bi, D.M. Slater, H. Ohmori, and C. Vaziri DNA polymerase kappa is specifically required for recovery from the benzo[a]pyrene-di-hydrodiol epoxide (BPDE)-induced S-phase checkpoint J. Biol. Chem. 280 2005 22343 22355
48. M.T. Washington, R.E. Johnson, S. Prakash, and L. Prakash Accuracy of thymine-thymine dimer bypass by Saccharomyces cerevisiae DNA polymerase eta Proc. Natl. Acad. Sci. U.S.A. 97 2000 3094 3099
49. L. Haracska, L. Prakash, and S. Prakash Role of human DNA polymerase κ as an extender in translesion synthesis Proc. Natl. Acad. Sci. U.S.A. 99 2002 16000 16005
50. K. Ramadan, I. Shevelev, and U. Hubscher The DNA-polymerase-X family: controllers of DNA quality? Nat. Mol. Cell. Biol. 5 2004 1038 1043
51. L.M. Chang, and F.J. Bollum Molecular biology of terminal transferase CRC Crit. Rev. Biochem. 21 1986 27 52
52. J. Suzumiya, K. Ohshima, M. Kikuchi, M. Takeshita, M. Akamatsu, and K. Tashiro Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma J. Pathol. 182 1997 86 91
53. Y. Zhang, X. Wu, F. Yuan, Z. Xie, and Z. Wang Highly frequent frameshift DNA synthesis by human DNA polymerase μ Mol. Cell. Biol. 23 2001 7995 8006
54. B. Tippin, S. Kobayashi, J.G. Bertram, and M.F. Goodman To slip or skip, visualizing frameshift mutation dynamics for error-prone DNA polymerases J. Biol. Chem. 279 2004 45360 45368
55. K. Bebenek, M. Garcia-Diaz, L. Blanco, and T.A. Kunkel The frameshift infidelity of human DNA polymerase lambda. Implications for function J. Biol. Chem. 278 2003 34685 34690
56. J.-B. Duvauchele, L. Blanco, R.P.P. Fuchs, and A.M. Cordonnier Human DNA polymerase mu (Pol μ) exhibits an unusual replication slippage ability at AAF lesion Nucleic Acids Res. 30 2002 2061 2067
57. Y. Zhang, X. Wu, D. Guo, O. Rechkoblit, J.-S. Taylor, N. Geacintov, and Z. Wang Lesion bypass activities of human DNA polymerase μ J. Biol. Chem. 46 2002 44582 44587
58. G. Blanca, G. Villani, I. Shevelev, K. Ramadan, S. Spadari, U. Hubscher, and G. Maga Human DNA polymerases λ and β show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation Biochemistry 43 2004 11605 11615
59. S. Covo, L. Blanco, and Z. Livneh Lesion bypass by human DNA polymerase μ reveals a template-dependent, sequence-independent nucleotidyl transferase activity J. Biol. Chem. 279 2004 859 865
60. K. Ramadan, I.V. Shevelev, G. Maga, and U. Hubscher De novo DNA synthesis by human DNA polymerase λ, DNA polymerase μ and terminal deoxyribonucleotidyl transferase J. Mol. Biol. 339 2004 395 404
61. M.R. Albertella, A. Lau, and M.J. O'Connor The overexpression of specialized DNA polymerases in cancer DNA Repair 4 2005 583 593
62. D. Starcevic, S. Dalal, and J.B. Sweasy Is there a link between DNA polymerase beta and cancer? Cell Cycle 3 2004 998 1001
63. T. Muto, M. Muramatsu, M. Taniwaki, K. Kinoshita, and T. Honjo Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene Genomics 68 2000 85 88
64. M. Muramatsu, V.S. Sankaranand, S. Anant, M. Sugai, K. Kinoshita, N.O. Davidson, and T. Honjo Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells J. Biol. Chem. 274 1999 18470 18476
65. S.K. Petersen-Mahrt, R.S. Harris, and M.S. Neuberger AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification Nature 418 2002 99 103
66. H. McCarthy, W.G. Wierda, L.L. Barron, C.C. Cromwell, J. Wang, K.R. Coombes, R. Rangel, K.S. Elenitoba-Johnson, M.J. Keating, and L.V. Abruzzo High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia Blood 101 2003 4903 4908
67. J. Greeve, A. Philipsen, K. Krause, W. Klapper, K. Heidorn, B.E. Castle, J. Janda, K.B. Marcu, and R. Parwaresch Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas Blood 101 2003 3574 3580
68. P. Oppezzo, F. Vuillier, Y. Vasconcelos, G. Dumas, C. Magnac, B. Payelle-Brogard, O. Pritsch, and G. Dighiero Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation Blood 101 2003 4029 4032
69. A.R. Ramiro, M. Jankovic, T. Eisenreich, S. Difilippantonio, S. Chen-Kiang, M. Muramatsu, T. Honjo, A. Nussenzweig, and M.C. Nussenzweig AID is required for c-myc/IgH chromosome translocations in vivo Cell 118 2004 431 438
70. R.S. Harris, S.K. Petersen-Mahrt, and M.S. Neuberger RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators Mol. Cell 10 2002 1247 1253
71. A. Martin, and M.D. Scharff Somatic hypermutation of the AID transgene in B and non-B cells Proc. Natl. Acad. Sci. U.S.A. 99 2002 12304 12308
72. A. Martin, P.D. Bardwell, C.J. Woo, M. Fan, M.J. Shulman, and M.D. Scharff Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas Nature 415 2002 802 806
73. S. Yamanaka, M.E. Balestra, L.D. Ferrell, J. Fan, K.S. Arnold, S. Taylor, J.M. Taylor, and T.L. Innerarity Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals Proc. Natl. Acad. Sci. U.S.A. 92 1995 8483 8487
74. I.M. Okazaki, H. Hiai, N. Kakazu, S. Yamada, M. Muramatsu, K. Kinoshita, and T. Honjo Constitutive expression of AID leads to tumorigenesis J. Exp. Med. 197 2003 1173 1181
75. S. Anant, and N.O. Davidson Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer? Trends Mol. Med. 9 2003 147 152
76. T.L. Wang, C. Rago, N. Silliman, J. Ptak, S. Markowitz, J.K.V. Willson, G. Parmigiani, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu Prevalence of somatic alterations in the colorectal cancer cell genome Proc. Natl. Acad. Sci. U.S.A. 99 2002 3076 3080
77. K. Machida, K.T.-N. Cheng, V.M.-H. Sung, S. Shimodaira, K.T. Lindsay, A.M. Levine, M.-Y. Lai, and M.M.C. Lai Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and proto-oncogenes Proc. Natl. Acad. Sci. U.S.A. 101 2004 4262 4267
78. L.A. Loeb, K.R. Loeb, and J.P. Anderson Multiple mutations and cancer Proc. Natl. Acad. Sci. U.S.A. 100 2003 776 781
79. I.P. Tomlinson, P. Sasieni, and W. Bodmer How many mutations in cancer? Am. J. Pathol. 100 2002 755 758
80. I. Tomlinson, and W. Bodmer Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog Nat. Med. 5 1999 11 12
81. P.A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard, R. Wooster, N. Rahman, and M.R. Stratton A census of human cancer genes Nat. Rev. Cancer 4 2004 117 183
82. J.H. Bielas, and L.A. Loeb Quantification of random genomic mutations Nat. Meth. 2 2005 285 290
83. M.F. Kane, M. Loda, G.M. Gaida, J. Lipman, R. Mishra, H. Goldman, J.M. Jessup, and R. Kolodner Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines Cancer Res. 57 1997 808 811
84. J.G. Herman, A. Umar, K. Polyak, J.R. Graff, N. Ahuja, J.P. Issa, S. Markowitz, J.K. Willson, S.R. Hamilton, K.W. Kinzler, M.F. Kane, R.D. Kolodner, B. Vogelstein, T.A. Kunkel, and S.B. Baylin Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Proc. Natl. Acad. Sci. U.S.A. 95 1998 6870 6875
85. J.P. Venables Aberrant and alternative splicing in cancer Cancer Res. 64 2004 7647 7654
86. J. Lasota, J.F. Fetsch, A. Wozniak, B. Wasag, R. Sciot, and M. Miettinen The neurofibromatosis type 2 gene is mutated in perineurial cell tumors. A molecular genetic study of eight cases Am. J. Pathol. 158 2001 1223 1229
87. E. Signori, C. Bagni, S. Papa, B. Primerano, M. Rinaldi, F. Amaldi, and V.M. Fazio A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency Oncogene 20 2001 4596 4600
88. N. Suraweera, B. Iacopetta, A. Duval, A. Compoint, E. Tubacher, and R. Hamelin Conservation of mononucleotide repeats within 3′ and 5′ untranslated regions and their instability in MSI-H colorectal cancer Oncogene 20 2001 7472 7477
89. 8 microsatellite abrogates expression regulation by 3′UTR Nucleic Acids Res. 31 2003 6561 6569
90. S. Seneca, H. Verhelst, L. De Meirleir, F. Meire, C. Ceuterick-De Groote, W. Lissens, and R. Van Coster A new mitochondrial point mutation in the transfer RNA(Leu) gene in a patient with a clinical phenotype resembling Kearns-Sayre syndrome Arch. Neurol. 58 2001 1113 1118
91. Leu(UUR) mutation at position 3264 Diabetes Care 26 2003 1942